1. Home
  2. KRRO vs TRT Comparison

KRRO vs TRT Comparison

Compare KRRO & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$14.08

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$10.29

Market Cap

124.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
TRT
Founded
2014
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
124.6M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
KRRO
TRT
Price
$14.08
$10.29
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$34.80
N/A
AVG Volume (30 Days)
247.6K
793.2K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$6,392,000.00
$32,462,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$555.00
Revenue Growth
181.46
N/A
52 Week Low
$5.20
$4.42
52 Week High
$55.89
$21.38

Technical Indicators

Market Signals
Indicator
KRRO
TRT
Relative Strength Index (RSI) 60.83 42.15
Support Level $10.32 $9.93
Resistance Level $14.41 $18.34
Average True Range (ATR) 1.32 1.60
MACD 0.20 -0.26
Stochastic Oscillator 76.14 3.57

Price Performance

Historical Comparison
KRRO
TRT

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About TRT Trio-Tech International

Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.

Share on Social Networks: